ENDURING INTERNET
From Cholesterol to Dyslipidemia: What Changed in the 2026 Guideline?
From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice - Understanding the New Dyslipidemia Paradigm (Webinar)
The shift from cholesterol-focused care to a broader dyslipidemia paradigm didn't happen overnight, and understanding why it happened is just as important as understanding what changed. In the first installment of this four-part CME/CE-accredited webinar series, moderator Kaye-Eileen Willard, MD, FNLA sits down with two members of the 2026 guideline writing and review committees to unpack the foundational changes clinicians need to know.
Topics covered include the new framework for atherogenic particle burden, the guideline's emphasis on early detection and cumulative exposure, changes to risk assessment and treatment thresholds using PREVENT, and how the updated recommendations affect clinicians across the full care team.
This webinar is a companion piece to the Month 1 podcast, Why the Dyslipidemia Guideline Had to Change. The two were designed to work together and reinforce each other, so we encourage you to check that out next.
Course Activities
-
Pre TestAssessment Required
-
WebinarContent Required
-
Post TestAssessment Required
-
EvaluationEvaluation Required
-
Credit ClaimCredit claim Required